TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7893790

Group type: EXPERIMENTAL
Intervention: Amoxycillin for 10 days
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Amoxycillin/clavulanic acid for 10 days
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Amoxycillin and Amoxycillin/clavulanic acid
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 58
Study: 2695999

Group type: EXPERIMENTAL
Intervention: Personalized prescription
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group (standard prescription)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Interview method for evaluation
Number of subjects: 180
Study: 405408

Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate (SCG) 4% solution instilled into each eye 4 times daily
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 31801712

Group type: EXPERIMENTAL
Intervention: Qingshen Granules (3 times a day)
Number of subjects: 60
Study: 28107729

Group type: EXPERIMENTAL
Intervention: Recombinant LH (rLH) supplementation (75 IU daily from day 7 of FSH stimulation to the day of HCG trigger)
Number of subjects: 100

Group type: COMPARATOR
Intervention: No additional rLH supplementation (control group)
Number of subjects: 100
Study: 25190522

Group type: EXPERIMENTAL
Intervention: 3 mg intranasal nicotine
Number of subjects: 89
Study: 23608774

Group type: EXPERIMENTAL
Intervention: Levobupivacaine 0.25% 1 ml/kg plus sufentanil 0.5 μg/kg (Group LS)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Levobupivacaine 0.25% 1 ml/kg only (Group L)
Number of subjects: 62
Study: 22229181

Group type: EXPERIMENTAL
Intervention: centrum combined with interbody bone graft fusion (group A)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: posterolateral bone graft fusion (group B)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: ring bone graft fusion (group C)
Number of subjects: 126
Study: 19423996

Group type: EXPERIMENTAL
Intervention: Acupuncture plus self-care
Number of subjects: 267

Group type: COMPARATOR
Intervention: Self-care alone
Number of subjects: 267
Study: 17545185

Group type: COMPARATOR
Intervention: Compression alone
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Compression plus surgery
Number of subjects: 500
Study: 16123223

Group type: EXPERIMENTAL
Intervention: R-CHOP (CHOP combined with rituximab)
Number of subjects: 428

Group type: COMPARATOR
Intervention: CHOP alone
Number of subjects: 428
Study: 12005088

Group type: EXPERIMENTAL
Intervention: q48h dosing schedule (5.0 or 4.5 mg/kg/dose q48h)
Number of subjects: 58

Group type: COMPARATOR
Intervention: q24h dosing schedule (2.5 or 3.0 mg/kg/dose q24h)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: q48h dosing schedule
Number of subjects: 58

Group type: COMPARATOR
Intervention: q24h dosing schedule
Number of subjects: 58
Study: 9597523

Group type: EXPERIMENTAL
Intervention: Abciximab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (standard therapy)
Number of subjects: 0
Study: 7806674

Group type: EXPERIMENTAL
Intervention: Chlorhexidine (Peridex) mouthrinse applied to the lower jaw for 21 days
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo mouthrinse applied to the lower jaw for 21 days
Number of subjects: 41
Study: 2550335

Group type: EXPERIMENTAL
Intervention: Kabi 2165 (low-molecular-weight heparin) 2 X 2,500 anti-Xa units s.c.
Number of subjects: 60
Study: 1098181

Group type: EXPERIMENTAL
Intervention: Parenteral administration of cephradine
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Oral administration of cephradine
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Open clinical trial
Number of subjects: 10
Study: 31958867

Group type: EXPERIMENTAL
Intervention: Homeopathic Calcarea carbonica ostrearum (CCO) in addition to a multidisciplinary intervention (diet, motivational support, and exercise program)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo in addition to a multidisciplinary intervention (diet, motivational support, and exercise program)
Number of subjects: 80
Study: 31178434

Group type: EXPERIMENTAL
Intervention: Metformin alone for 12 months
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Insulin glargine for 3 months followed by metformin for 9 months
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Liraglutide combined with metformin for 12 months
Number of subjects: 267

Group type: COMPARATOR
Intervention: Placebo for 12 months
Number of subjects: 267
Study: 28076496

Group type: EXPERIMENTAL
Intervention: Clinpro XT (resin-modified glass ionomer cement)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Vidrion R (conventional glass ionomer cement)
Number of subjects: 20
Study: 25291499

Group type: EXPERIMENTAL
Intervention: Dutasteride (0.5 mg daily for 8 weeks)
Number of subjects: 259

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 259
Study: 23659710

Group type: EXPERIMENTAL
Intervention: Nurse‐led structured diabetes care with a protocol, record keeping, reminders, feedback, and training in motivational interviewing and agenda setting
Number of subjects: 940
Study: 21798658

Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA 200 U
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA 300 U
Number of subjects: 275

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 275
Study: 18465191

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) after subgingival scaling and root planing
Number of subjects: 24

Group type: COMPARATOR
Intervention: Subgingival scaling and root planing alone (control)
Number of subjects: 24
Study: 16952896

Group type: EXPERIMENTAL
Intervention: Panic disorder-related automatic thoughts
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Social phobia-related automatic thoughts
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Diagnosis-related automatic thoughts (panic and social phobia)
Number of subjects: 62
Study: 12622347

Group type: EXPERIMENTAL
Intervention: d-amphetamine (10 mg)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 109
Study: 14971587

Group type: EXPERIMENTAL
Intervention: Levodopa (2 mg/kg body weight)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control (normal subjects)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Baseline comparison
Number of subjects: 15
Study: 9588605

Group type: EXPERIMENTAL
Intervention: Functional knee brace (FKB) during aLT tests
Number of subjects: 13

Group type: COMPARATOR
Intervention: No brace during aLT tests
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Functional knee brace (FKB) during bLT tests
Number of subjects: 13

Group type: COMPARATOR
Intervention: No brace during bLT tests
Number of subjects: 13
Study: 8751022

Group type: EXPERIMENTAL
Intervention: 4% erythromycin plus 1.2% zinc (Zineryt lotion)
Number of subjects: 14

Group type: COMPARATOR
Intervention: 4% erythromycin lotion (control)
Number of subjects: 14
Study: 2371595

Group type: EXPERIMENTAL
Intervention: Portable sleep apnea screening device
Number of subjects: 67

Group type: COMPARATOR
Intervention: Standard polysomnographic techniques
Number of subjects: 67
Study: 90768

Group type: EXPERIMENTAL
Intervention: Concurrent induced-abortion/sterilisation group
Number of subjects: 406

Group type: COMPARATOR
Intervention: Interval sterilisation group
Number of subjects: 406
Study: 31395505

Group type: EXPERIMENTAL
Intervention: Anti-VEGF treatment
Number of subjects: 986
Study: 28620272

Group type: EXPERIMENTAL
Intervention: Brief Intervention (BI)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Education Comparison (EC)
Number of subjects: 61
Study: 26564297

Group type: EXPERIMENTAL
Intervention: Sugammadex (2 mg/kg intravenously)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Neostigmine/atropine combination (0.05 mg/kg neostigmine and 0.02 mg/kg atropine)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Comparison of heart rate and mean arterial pressure
Number of subjects: 36
Study: 24277116

Group type: EXPERIMENTAL
Intervention: pemetrexed + carboplatin
Number of subjects: 105

Group type: COMPARATOR
Intervention: docetaxel + carboplatin
Number of subjects: 105
Study: 22319751

Group type: EXPERIMENTAL
Intervention: Ethanol‐wet bonding with experimental hydrophobic adhesive (UT group)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Water‐wet bonding
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Ethanol‐wet bonding with commercial hydrophilic adhesive (SB)
Number of subjects: 66
Study: 19537837

Group type: EXPERIMENTAL
Intervention: Formoterol plus tiotropium
Number of subjects: 155

Group type: COMPARATOR
Intervention: Placebo plus tiotropium
Number of subjects: 155
Study: 16600415

Group type: EXPERIMENTAL
Intervention: Sequential changes in fasting plasma glucose (FPG) levels within the normoglycemic range (FPG<100 mg/dl)
Number of subjects: 5296

Group type: COMPARATOR
Intervention: Normoglycemic subjects
Number of subjects: 5296

Group type: COMPARATOR
Intervention: Subjects with impaired fasting glucose
Number of subjects: 5296
Study: 15175438

Group type: EXPERIMENTAL
Intervention: Obese children and adolescents
Number of subjects: 490

Group type: EXPERIMENTAL
Intervention: Overweight and obese subjects
Number of subjects: 490

Group type: EXPERIMENTAL
Intervention: Increasing obesity
Number of subjects: 490
Study: 11342912

Group type: EXPERIMENTAL
Intervention: Transurethral microwave thermotherapy (Prostatron)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Transurethral prostatic resection
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Transurethral microwave thermotherapy
Number of subjects: 155
Study: 9212146

Group type: EXPERIMENTAL
Intervention: I.V. clonidine (3 microg/kg)
Number of subjects: 39

Group type: COMPARATOR
Intervention: I.V. saline
Number of subjects: 39
Study: 8132365

Group type: EXPERIMENTAL
Intervention: Azithromycin 500 mg once daily for 10 days
Number of subjects: 32

Group type: COMPARATOR
Intervention: Penicillin V 1 million U three times daily for 10 days
Number of subjects: 32
Study: 29795028

Group type: EXPERIMENTAL
Intervention: Vocational school students
Number of subjects: 140

Group type: COMPARATOR
Intervention: High school students
Number of subjects: 140
Study: 27596801

Group type: EXPERIMENTAL
Intervention: Probiotic group (n=10) received Lactobacillus rhamnosus SP1 at a dose of 3×10^9 cfu/day (75 mg/day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo group (n=10) received a liquid lacking probiotics
Number of subjects: 20
Study: 24145847

Group type: EXPERIMENTAL
Intervention: Noninvasive mechanical ventilation (NIV)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Marketed device with an off‐switch for use during swallowing
Number of subjects: 15

Group type: COMPARATOR
Intervention: Standard mechanical ventilator capable of delivering NIV
Number of subjects: 15
Study: 22385118

Group type: EXPERIMENTAL
Intervention: Gonadotropin treatment (GnTh) using β Human Chorionic Gonadotropin (β HCG) and Follicle Stimulating Hormone (FSH) for up to 30 months.
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (CG) of 35 healthy and fertile men.
Number of subjects: 23
Study: 20299823

Group type: EXPERIMENTAL
Intervention: Urinary cotinine (UC)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Breath carbon monoxide (CO)
Number of subjects: 164
Study: 18211450

Group type: EXPERIMENTAL
Intervention: Airtraq laryngoscope
Number of subjects: 40

Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 40
Study: 16148244

Group type: EXPERIMENTAL
Intervention: Accompanied visits
Number of subjects: 30

Group type: COMPARATOR
Intervention: Unaccompanied visits
Number of subjects: 30
Study: 12475576

Group type: EXPERIMENTAL
Intervention: Misoprostol 50 microg per vagina every 4 h as needed
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Dinoprostone 0.5 mg doses given intra-cervically every 6 h
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 84
Study: 10391423

Group type: EXPERIMENTAL
Intervention: Monitoring with antifactor Xa heparin activity (HA)
Number of subjects: 268

Group type: COMPARATOR
Intervention: Monitoring with activated partial thromboplastin time (aPTT)
Number of subjects: 268
Study: 8655902

Group type: EXPERIMENTAL
Intervention: Fortified formula (alpha-linolenic acid 1.8 g/day, arginine 7.8 g/day, RNA 0.75 g/day)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control formula
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Fortified formula
Number of subjects: 10
Study: 1504111

Group type: EXPERIMENTAL
Intervention: 20 mg yohimbine
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Alprazolam treatment
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Mental arithmetic task
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Continuous performance task
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Yohimbine
Number of subjects: 27
Study: 6746158

Group type: EXPERIMENTAL
Intervention: Viewing alcohol-related slides
Number of subjects: 16

Group type: COMPARATOR
Intervention: Viewing non-alcohol-related slides
Number of subjects: 16
Study: 29404890

Group type: EXPERIMENTAL
Intervention: Supreme™ LMA (SLMA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Proseal™ LMA (PLMA)
Number of subjects: 60
Study: 26726986

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation device
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard nonoperative modalities
Number of subjects: 0
Study: 18252029

Group type: EXPERIMENTAL
Intervention: Midazolam and Ketamine
Number of subjects: 114

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Midazolam and Ketamine (Cyanotic subgroup)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Propofol (Cyanotic subgroup)
Number of subjects: 114
Study: 21931958

Group type: EXPERIMENTAL
Intervention: Mindfulness training (8-week course)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 0
Study: 18696227

Group type: EXPERIMENTAL
Intervention: Fear elicitation task (N = 33)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Frustration elicitation task (N = 32)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Validity check condition (N = 8)
Number of subjects: 73
Study: 17935933

Group type: EXPERIMENTAL
Intervention: Sufentanil 5 microg and Clonidine 30 microg (C30)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Sufentanil 10 microg (S10)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Sufentanil 5 microg (S5)
Number of subjects: 105
Study: 15864406

Group type: EXPERIMENTAL
Intervention: Feature fusion mechanism in schizophrenia
Number of subjects: 0
Study: 12462952

Group type: EXPERIMENTAL
Intervention: Dietary supplement 'ExPress'
Number of subjects: 24
Study: 9833720

Group type: EXPERIMENTAL
Intervention: Autologous cryoprecipitate
Number of subjects: 32

Group type: COMPARATOR
Intervention: Conventional fibrin glue
Number of subjects: 32
Study: 8209990

Group type: EXPERIMENTAL
Intervention: Stifneck cervical collar
Number of subjects: 9

Group type: COMPARATOR
Intervention: No cervical collar
Number of subjects: 9
Study: 2684078

Group type: EXPERIMENTAL
Intervention: Oral ciprofloxacin (750 mg every 12 hours)
Number of subjects: 570

Group type: COMPARATOR
Intervention: Intravenous cefotaxime (2.0 g every 8 hours)
Number of subjects: 570

Group type: EXPERIMENTAL
Intervention: Oral ciprofloxacin
Number of subjects: 570
Study: 240378

Group type: EXPERIMENTAL
Intervention: Atenolol (50 mg oral dose)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 5
Study: 31581926

Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan initiation
Number of subjects: 143
Study: 30707238

Group type: EXPERIMENTAL
Intervention: Curved suture anchor insertion technique
Number of subjects: 20

Group type: COMPARATOR
Intervention: Straight suture anchor insertion technique
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Anchors that perforated the glenoid
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Anchors that did not perforate the glenoid
Number of subjects: 20
Study: 28340098

Group type: EXPERIMENTAL
Intervention: Fluoride-containing adhesive resin
Number of subjects: 34

Group type: COMPARATOR
Intervention: Non-fluoride-containing adhesive resin
Number of subjects: 34
Study: 26092821

Group type: EXPERIMENTAL
Intervention: Nordic walking 5h/week for 4 months
Number of subjects: 201

Group type: COMPARATOR
Intervention: Control group (ordinary activities)
Number of subjects: 201
Study: 23869185

Group type: COMPARATOR
Intervention: Remifentanil at infusion rate of 0.1 μg·kg(‐1)·min(‐1) (Group L)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Remifentanil at infusion rate of 0.5 μg·kg(‐1)·min(‐1) (Group H)
Number of subjects: 37
Study: 21047149

Group type: EXPERIMENTAL
Intervention: Maintenance treatment for opioid dependence
Number of subjects: 1015

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 1015

Group type: COMPARATOR
Intervention: Patients diagnosed with schizophrenia
Number of subjects: 1015

Group type: COMPARATOR
Intervention: Patients diagnosed with depression
Number of subjects: 1015
Study: 19701514

Group type: EXPERIMENTAL
Intervention: Mechanical roughening with a diamond‐coated bur
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Etching with citric acid
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Application of EDTA C
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Luting with Panavia 2.0 F
Number of subjects: 216

Group type: COMPARATOR
Intervention: Luting with Rely X Unicem or ParaCem
Number of subjects: 216

Group type: COMPARATOR
Intervention: Control group (no pretreatment)
Number of subjects: 216
Study: 17296307

Group type: EXPERIMENTAL
Intervention: Cefazolin
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Amoxicillin-clavulanate
Number of subjects: 189
Study: 15022297

Group type: EXPERIMENTAL
Intervention: Accelerated radiotherapy with carboplatin chemotherapy
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Conventional radiotherapy with carboplatin chemotherapy
Number of subjects: 204

Group type: COMPARATOR
Intervention: Radiotherapy without carboplatin chemotherapy
Number of subjects: 204
Study: 11750220

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GR‐1/Lactobacillus fermentum RC‐14 (once and twice daily)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Lactobacillus rhamnosus GG
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GR‐1/Lactobacillus fermentum RC‐14
Number of subjects: 42
Study: 9504572

Group type: EXPERIMENTAL
Intervention: Common iliac venous pressure (CIVP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Superior vena cava pressure (SVCP)
Number of subjects: 20
Study: 8000301

Group type: EXPERIMENTAL
Intervention: 30 mg of beta-carotene (BC) daily for 3 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2725335

Group type: EXPERIMENTAL
Intervention: Nomegestrol acetate 0.5 mg daily
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Nomegestrol acetate 1.0 mg daily
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Nomegestrol acetate 2.5 mg daily
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (oestrogen therapy only)
Number of subjects: 36
Study: 781439

Group type: EXPERIMENTAL
Intervention: 410 mg of prednisone plus vitamins in descending doses over 10 days
Number of subjects: 51

Group type: COMPARATOR
Intervention: Vitamins
Number of subjects: 51
Study: 31647350

Group type: EXPERIMENTAL
Intervention: Laparoscopic needle assisted hernia repair (LNAR)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Open herniotomy (OH)
Number of subjects: 32
Study: 30200193

Group type: EXPERIMENTAL
Intervention: Ketogenic Diet (KD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: American Cancer Society diet (ACS)
Number of subjects: 0
Study: 26351263

Group type: EXPERIMENTAL
Intervention: Cyber Friendly Schools program (CFS) implemented in Grades 8 and 9 (aged 13-14 years)
Number of subjects: 3000

Group type: COMPARATOR
Intervention: Usual practice control group
Number of subjects: 3000
Study: 24916707

Group type: EXPERIMENTAL
Intervention: Ivy leaves dry extract
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 22306626

Group type: EXPERIMENTAL
Intervention: Fatigue Management Group (FMG)
Number of subjects: 19

Group type: COMPARATOR
Intervention: General Stroke Education (GSE)
Number of subjects: 19
Study: 20105150

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (1.0 microg.kg(‐1) over 10 min)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Propofol target controlled infusion
Number of subjects: 40
Study: 17481578

Group type: EXPERIMENTAL
Intervention: Acute psychological stress (induced by a frustrating computer task)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control condition (no acute psychological stress)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: High chronic stress group (post hoc division based on chronic daily stress questionnaire)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Low chronic stress group (post hoc division based on chronic daily stress questionnaire)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Chronic stress (high vs low)
Number of subjects: 59
Study: 15677573

Group type: EXPERIMENTAL
Intervention: Estrogen therapy
Number of subjects: 664
Study: 12406377

Group type: EXPERIMENTAL
Intervention: Clearfil SE Bond (self-etching-priming system)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Prime & Bond NT (one-bottle system)
Number of subjects: 36
Study: 10487100

Group type: EXPERIMENTAL
Intervention: BMI > 30 (obesity)
Number of subjects: 1940

Group type: EXPERIMENTAL
Intervention: Younger men and women with less than seven years of school education
Number of subjects: 1940
Study: 8767528

Group type: EXPERIMENTAL
Intervention: Dexamethasone, vincristine, doxorubicin, idarubicin, or mitoxantrone
Number of subjects: 89

Group type: COMPARATOR
Intervention: MDR positivity
Number of subjects: 89
Study: 2342818

Group type: EXPERIMENTAL
Intervention: Oral immunization with inactivated influenza vaccine (Mississippi 1/85; dosage: 110 micrograms HA)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 6114968

Group type: EXPERIMENTAL
Intervention: Directed masturbation (DM)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Systematic desensitization (SD)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Waiting list control (WL)
Number of subjects: 30